Results 41 to 50 of about 2,293 (210)

Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors. [PDF]

open access: yes, 2015
All gynecologists are faced with ovarian tumors on a regular basis, and the accurate preoperative diagnosis of these masses is important because appropriate management depends on the type of tumor. Recently, the International Ovarian Tumor Analysis (IOTA)
Anthoulakis, C   +9 more
core   +1 more source

Krukenberg tumor which cause virilization female fetus – case report.

open access: yesJournal of Education, Health and Sport, 2019
We present a case of a patient diagnosed in the 3rd trimester of pregnancy with a Krukenberg tumor being a metastasis of stomach cancer. Due to severe pre-eclampsia, the pregnancy was solved by Caesarean section, a female child was born with severe ...
Klaudia Marzena Długoborska   +2 more
doaj   +3 more sources

A Rare Case of Breast Cancer Metastasis to the Eyelid

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Metastasis to eyelids is a rare condition with a poor prognosis, presenting with nonspecific symptoms. Diagnosis can be challenging in such cases, but it is important to consider metastatic disease as one of the differential diagnoses of eyelid lesions in cancer patients.
Karuna Khadka   +4 more
wiley   +1 more source

Intraperitoneal chemotherapy for peritoneal metastases : an expert opinion

open access: yes, 2020
Introduction: The rationale for intraperitoneal (IP) drug delivery for patients with peritoneal metastases (PM) is based on the pharmacokinetic advantage resulting from the peritoneal-plasma barrier, and on the potential to adequately treat small, poorly
Braet, Helena   +4 more
core   +1 more source

Krukenberg tumor due to gastric cancer in pregnancy – Report of 2 cases

open access: yesJournal of Pediatric and Neonatal Individualized Medicine, 2022
Krukenberg tumors (KTs) are 1-2% of all ovarian tumors, they are rare in pregnancy, and they have a poor prognosis since they are detected in advanced stages. We report 2 cases of KT in pregnancy. Bilateral giant solid adnexal masses were detected at the
Esra Altan Erbilen   +4 more
doaj   +1 more source

Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women

open access: yesClinical Endocrinology, Volume 103, Issue 4, Page 540-566, October 2025.
ABSTRACT Context Androgen excess is common in women and refers to clinical or biochemical evidence of elevated androgenic steroids such as testosterone. It is associated with underlying polycystic ovary syndrome in the majority of cases. However severe androgen excess is less common and may indicate the presence of underlying adrenal or ovarian ...
Yasir S. Elhassan   +14 more
wiley   +1 more source

Krukenberg tumor in a young female arising from a primary adenocarcinoma of stomach: a case report [PDF]

open access: yes, 2021
Krukenberg tumor is a malignancy of ovary that metastasizes from a primary site. Krukenberg tumors are uncommon and account for less than 2% of all ovarian tumors.
Davda, Mansi   +3 more
core   +2 more sources

Cancer of the ovary, fallopian tube, and peritoneum: 2025 update

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 6-35, September 2025.
Abstract In 2014, FIGO's Committee for Gynecologic Oncology revised the staging of ovarian cancer, incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of these malignancies are high‐grade serous carcinomas (HGSCs).
Malte Renz   +2 more
wiley   +1 more source

Neuroendocrine Cancer of Rectum Metastasizing to Ovary

open access: yesCase Reports in Oncological Medicine, 2016
Neuroendocrine carcinomas (NECs) are rare malignancies that originate from the hormone-producing cells of the body’s neuroendocrine system. Rectal high grade NEC (HG-NEC) constituting less than 1% of colorectal cancers can cause large ovarian metastasis ...
Sapna Vinit Amin   +6 more
doaj   +1 more source

Vascular Disrupting Agent Drug Classes Differ in Effects on the Cytoskeleton [PDF]

open access: yes, 2012
Vascular disrupting agents (VDAs), anti-cancer drugs that target established tumor blood vessels, fall into two main classes: microtubule targeting drugs, exemplified by combretastatin A4 (CA4), and flavonoids, exemplified by 5,6-dimethylxanthenone-4 ...
Kim, Sujeong   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy